MAXIM PHARMACEUTICALS INC
S-3, EX-23.2, 2000-07-14
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Previous: MAXIM PHARMACEUTICALS INC, S-3, EX-23.1, 2000-07-14
Next: AMERICAN TELESOURCE INTERNATIONAL INC, S-3/A, 2000-07-14



<PAGE>

                                                               EXHIBIT 23.2

          CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS


We consent to the reference to our firm under the caption "Experts" in the
Registration Statement (Form S-3) and related Prospectus of Maxim
Pharmaceuticals, Inc. for the registration of 1,552,775 shares of its common
stock and to the incorporation by reference therein of our report dated March
24, 2000, with respect to the financial statements of Cytovia, Inc. included
in the Current Report on Form 8-K of Maxim Pharmaceuticals, Inc., filed with
the Securities and Exchange Commission on June 30, 2000.

                                                           /s/Ernst & Young LLP
                                                           --------------------
                                                           Ernst & Young LLP


San Diego, California
July 13, 2000






© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission